Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aratana Therapeutics, Inc. (PETX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aratana Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1509190.
Total stock buying since 2014: $0.
Total stock sales since 2014: $14,398,835.
Total stock option exercises since 2014: $414,745.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 0 | $0 | 3,125 | $13,093 | 0 | $0 |
| 2018 | 0 | $0 | 238,487 | $1,353,587 | 0 | $0 |
| 2017 | 0 | $0 | 1,110,516 | $6,552,071 | 75,333 | $236,545 |
| 2016 | 0 | $0 | 287,806 | $2,145,621 | 0 | $0 |
| 2015 | 0 | $0 | 169,307 | $3,069,960 | 0 | $0 |
| 2014 | 0 | $0 | 90,000 | $1,264,503 | 29,700 | $178,200 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-01 | 0 | $0 | 3,125 | $13,093 | 0 | $0 |
| 2018-12 | 0 | $0 | 46,094 | $269,788 | 0 | $0 |
| 2018-11 | 0 | $0 | 20,000 | $138,999 | 0 | $0 |
| 2018-10 | 0 | $0 | 11,513 | $67,454 | 0 | $0 |
| 2018-09 | 0 | $0 | 75,000 | $454,275 | 0 | $0 |
| 2018-08 | 0 | $0 | 15,000 | $77,249 | 0 | $0 |
| 2018-07 | 0 | $0 | 11,513 | $49,839 | 0 | $0 |
| 2018-06 | 0 | $0 | 10,000 | $45,640 | 0 | $0 |
| 2018-01 | 0 | $0 | 49,367 | $250,343 | 0 | $0 |
| 2017-12 | 0 | $0 | 562,428 | $3,089,979 | 28,667 | $90,014 |
| 2017-11 | 0 | $0 | 378,088 | $2,363,312 | 0 | $0 |
| 2017-10 | 0 | $0 | 50,000 | $312,100 | 0 | $0 |
| 2017-09 | 0 | $0 | 20,000 | $123,630 | 0 | $0 |
| 2017-04 | 0 | $0 | 50,000 | $277,150 | 46,666 | $146,531 |
| 2017-01 | 0 | $0 | 50,000 | $385,900 | 0 | $0 |
| 2016-12 | 0 | $0 | 50,000 | $381,400 | 0 | $0 |
| 2016-10 | 0 | $0 | 10,000 | $100,010 | 0 | $0 |
| 2016-09 | 0 | $0 | 30,000 | $277,590 | 0 | $0 |
| 2016-08 | 0 | $0 | 50,000 | $462,500 | 0 | $0 |
| 2016-06 | 0 | $0 | 145,000 | $914,685 | 0 | $0 |
| 2016-02 | 0 | $0 | 2,806 | $9,436 | 0 | $0 |
| 2015-11 | 0 | $0 | 3,620 | $27,236 | 0 | $0 |
| 2015-10 | 0 | $0 | 3,250 | $26,188 | 0 | $0 |
| 2015-07 | 0 | $0 | 15,000 | $255,825 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-30 | Ayres John C (SEE REMARKS) | Sale | 3,125 | 4.19 | 13,093 |
| 2018-12-17 | St Peter Steven (PRESIDENT AND CEO) | Sale | 46,094 | 5.85 | 269,788 |
| 2018-11-07 | Heinen Ernst (Chief Development Officer) | Sale | 19,308 | 6.95 | 134,190 |
| 2018-11-02 | Heinen Ernst (Chief Development Officer) | Sale | 692 | 6.95 | 4,809 |
| 2018-10-30 | St Peter Steven (PRESIDENT AND CEO) | Sale | 11,513 | 5.86 | 67,454 |
| 2018-09-21 | St Peter Steven (PRESIDENT AND CEO) | Sale | 75,000 | 6.06 | 454,275 |
| 2018-08-14 | Heinen Ernst (Chief Development Officer) | Sale | 1,712 | 5.15 | 8,816 |
| 2018-08-13 | Heinen Ernst (Chief Development Officer) | Sale | 8,660 | 5.15 | 44,599 |
| 2018-08-10 | Heinen Ernst (Chief Development Officer) | Sale | 1,954 | 5.15 | 10,063 |
| 2018-08-08 | Heinen Ernst (Chief Development Officer) | Sale | 2,674 | 5.15 | 13,771 |
| 2018-07-30 | St Peter Steven (PRESIDENT AND CEO) | Sale | 11,513 | 4.33 | 49,839 |
| 2018-06-25 | Standridge Brent (Chief Operating Officer) | Sale | 10,000 | 4.56 | 45,640 |
| 2018-01-30 | St Peter Steven (PRESIDENT AND CEO) | Sale | 19,367 | 4.77 | 92,303 |
| 2018-01-11 | Tooman Craig A (CHIEF FINANCIAL OFFICER) | Sale | 30,000 | 5.27 | 158,040 |
| 2017-12-21 | Tooman Craig A (CHIEF FINANCIAL OFFICER) | Option Ex | 2,000 | 3.14 | 6,280 |
| 2017-12-20 | St Peter Steven (PRESIDENT AND CEO) | Option Ex | 26,667 | 3.14 | 83,734 |
| 2017-12-01 | Kotler Kevin | Sale | 562,428 | 5.49 | 3,089,979 |
| 2017-11-30 | Kotler Kevin | Sale | 211,572 | 5.96 | 1,260,969 |
| 2017-11-29 | Kotler Kevin | Sale | 116,516 | 6.46 | 752,343 |
| 2017-11-10 | St Peter Steven (PRESIDENT AND CEO) | Sale | 50,000 | 7.00 | 350,000 |
| 2017-10-02 | St Peter Steven (PRESIDENT AND CEO) | Sale | 50,000 | 6.24 | 312,100 |
| 2017-09-25 | Standridge Brent (Chief Operating Officer) | Sale | 10,000 | 6.11 | 61,130 |
| 2017-09-15 | Heinen Ernst (Chief Development Officer) | Sale | 10,000 | 6.25 | 62,500 |
| 2017-04-17 | St Peter Steven (PRESIDENT AND CEO) | Sale | 50,000 | 5.54 | 277,150 |
| 2017-04-17 | St Peter Steven (PRESIDENT AND CEO) | Option Ex | 46,666 | 3.14 | 146,531 |
| 2017-01-27 | St Peter Steven (PRESIDENT AND CEO) | Sale | 50,000 | 7.72 | 385,900 |
| 2016-12-15 | St Peter Steven (PRESIDENT AND CEO) | Sale | 50,000 | 7.63 | 381,400 |
| 2016-10-03 | Heinen Ernst (Chief Development Officer) | Sale | 10,000 | 10.00 | 100,010 |
| 2016-09-09 | Tooman Craig A (CHIEF FINANCIAL OFFICER) | Sale | 30,000 | 9.25 | 277,590 |
| 2016-08-09 | St Peter Steven (PRESIDENT AND CEO) | Sale | 50,000 | 9.25 | 462,500 |
| 2016-06-28 | Stephanus Julia A (CHIEF COMMERCIAL OFFICER) | Sale | 30,000 | 6.25 | 187,500 |
| 2016-06-17 | St Peter Steven (PRESIDENT AND CEO) | Sale | 25,000 | 6.32 | 158,025 |
| 2016-06-16 | St Peter Steven (PRESIDENT AND CEO) | Sale | 75,000 | 6.24 | 468,300 |
| 2016-06-10 | Heinen Ernst (Chief Development Officer) | Sale | 15,000 | 6.72 | 100,860 |
| 2016-02-01 | Tooman Craig A (CHIEF FINANCIAL OFFICER) | Sale | 2,806 | 3.36 | 9,436 |
| 2015-11-09 | Tooman Craig A (CHIEF FINANCIAL OFFICER) | Sale | 3,620 | 7.52 | 27,236 |
| 2015-10-02 | Tooman Craig A (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 8.06 | 26,188 |
| 2015-07-15 | Heinen Ernst (Chief Development Officer) | Sale | 15,000 | 17.05 | 255,825 |
| 2015-04-27 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Sale | 15,000 | 15.28 | 229,185 |
| 2015-03-06 | Vander Vort John (Director) | Sale | 6,137 | 20.01 | 122,776 |
| 2015-03-06 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Sale | 20,000 | 20.00 | 400,000 |
| 2015-01-13 | Stephanus Julia A (CHIEF COMMERCIAL OFFICER) | Sale | 6,300 | 19.00 | 119,700 |
| 2015-01-13 | St Peter Steven (PRESIDENT AND CEO) | Sale | 75,000 | 19.23 | 1,442,400 |
| 2015-01-02 | St Peter Steven (PRESIDENT AND CEO) | Sale | 25,000 | 17.87 | 446,650 |
| 2014-12-22 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Sale | 10,000 | 18.00 | 180,000 |
| 2014-10-06 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Option Ex | 4,700 | 6.00 | 28,200 |
| 2014-09-03 | St Peter Steven (PRESIDENT AND CEO) | Option Ex | 25,000 | 6.00 | 150,000 |
| 2014-09-02 | St Peter Steven (PRESIDENT AND CEO) | Sale | 25,000 | 11.68 | 291,875 |
| 2014-07-03 | Stephanus Julia A (CHIEF COMMERCIAL OFFICER) | Sale | 2,000 | 17.33 | 34,660 |
| 2014-07-01 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Sale | 10,000 | 16.00 | 160,000 |
| 2014-06-17 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Sale | 4,626 | 15.00 | 69,390 |
| 2014-06-16 | Stephanus Julia A (CHIEF COMMERCIAL OFFICER) | Sale | 8,000 | 13.90 | 111,168 |
| 2014-06-09 | Rhodes Linda (CHIEF SCIENTIFIC OFFICER) | Sale | 5,374 | 15.00 | 80,610 |
| 2014-06-02 | St Peter Steven (PRESIDENT AND CEO) | Sale | 25,000 | 13.47 | 336,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of PETX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aratana Therapeutics, Inc. (symbol PETX, CIK number 1509190) see the Securities and Exchange Commission (SEC) website.